TOPICAL ANTIFUNGALS Rx-TO-OTC SWITCH FOR CANDIDIASIS RECOMMENDED BY FDA ADVISORY COMITTEE; LABELING SHOULD FLAG FIRST-TIMERS, CHRONIC INFECTIONS